Actos was not taken off the market in the United States. The FDA required Takeda Pharmaceuticals to add a warning to the Actos label that clarified the increased risk of major side effects. In 2011, France and Germany took Actos off the market after a study showed the link between the drug and bladder cancer and heart problems. India’s government has also banned Actos.